stella
beta
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs — Stella
Recruiting
Back to HIV trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(2 sites)
United States
Massachusetts General Hospital, Boston, Massachusetts
Fenway Health, Boston, Massachusetts
View full record on ClinicalTrials.gov